文献速递心脑血管急症重症综合管理与镇静镇痛

射血分数降低的心力衰竭合并心房颤动在急诊科的急性处理

Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department.
PubMed 文献 · Am J Emerg Med · 2022-04-06
一句话结论HFrEF合并AF快速心室率患者急诊静脉用地尔硫䓬与美托洛尔总不良事件无差异,但地尔硫䓬组心衰恶化症状更多(33% vs 15%,P=0.019)。

本研究为单中心回顾性研究,纳入125例≥18岁HFrEF合并AF快速心室率且在急诊接受静脉地尔硫䓬或美托洛尔的患者,地尔硫䓬组57例、美托洛尔组68例。主要终点总不良事件两组相似(32% vs 21%,P=0.217),但地尔硫䓬组心衰恶化症状(4小时内氧需求增加或48小时内启动正性肌力支持)显著更高(33% vs 15%,P=0.019)。60分钟心率控制失败率两组无显著差异(51% vs 62%,P=0.277)。提示对HFrEF合并AF快速心室率患者,地尔硫䓬可能与心衰恶化相关。

要点

  • HFrEF合并AF快速心室率急诊静脉地尔硫䓬组心衰恶化症状(4小时内氧需求增加或48小时内启动正性肌力支持)33% vs 美托洛尔组15%,P=0.019。
  • 总不良事件(低血压需补液或升压药、心率<60次/分、心衰恶化)地尔硫䓬32% vs 美托洛尔21%,P=0.217,无显著差异。
  • 60分钟心率控制失败率地尔硫䓬51% vs 美托洛尔62%,P=0.277,无显著差异。
  • 美国心脏协会等临床组织指出HFrEF患者应避免使用非二氢吡啶类钙通道阻滞剂,因其潜在负性肌力作用,但指导该推荐的证据很少。

适用人群与场景

  • ≥18岁射血分数降低的心力衰竭(HFrEF)患者,在急诊科表现为心房颤动(AF)伴快速心室率(RVR),并接受静脉地尔硫䓬或美托洛尔治疗。

研究设计与关键结果

  • 单中心回顾性研究,纳入125例HFrEF合并AF快速心室率患者,地尔硫䓬组57例、美托洛尔组68例。
  • 主要终点总不良事件:地尔硫䓬32% vs 美托洛尔21%,P=0.217,无显著差异。
  • 心衰恶化症状(4小时内氧需求增加或48小时内启动正性肌力支持):地尔硫䓬33% vs 美托洛尔15%,P=0.019,地尔硫䓬组显著更高。
  • 60分钟心率控制失败率:地尔硫䓬51% vs 美托洛尔62%,P=0.277,无显著差异。

证据类型、等级与局限

  • 单中心回顾性研究。
  • 美国心脏协会等临床组织指出HFrEF患者应避免使用非二氢吡啶类钙通道阻滞剂,因其潜在负性肌力作用,但指导该推荐的证据很少。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对HFrEF合并AF快速心室率患者急诊静脉用地尔硫䓬时,需警惕4小时内氧需求增加或48小时内启动正性肌力支持等心衰恶化表现(地尔硫䓬组33% vs 美托洛尔组15%,P=0.019)。
  • 美国心脏协会等临床组织指出HFrEF患者应避免使用非二氢吡啶类钙通道阻滞剂,但原文指出指导该推荐的证据很少。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: Acute heart rate control for atrial fibrillation (AF) with rapid ventricular response (RVR) in the emergency department (ED) is often achieved utilizing intravenous (IV) non-dihydropyridine calcium channel blockers (CCB) or beta blockers (BB). For patients with concomitant heart failure with a reduced ejection fraction (HFrEF), the American Heart Association and other clinical groups note that CCB should be avoided due to their potential negative inotropic effects. However, minimal evidence exists to guide this current recommendation. The primary objective of this study was to compare the incidence of adverse effects in the HFrEF patient population whose AF with RVR was treated with IV diltiazem or metoprolol in the ED.

METHODS: This single center, retrospective review included patients ≥18 years old with HFrEF who presented in AF with RVR and received IV diltiazem or metoprolol in the ED. The primary outcome was adverse effects of therapy defined as: 1) hypotension (systolic blood pressure < 90 mmHg requiring fluid bolus or vasopressors) or bradycardia (heart rate < 60 beats/min) within 60 min of medication administration 2) worsening heart failure symptoms defined as increased oxygen requirements within four hours or inotropic support within 48 h. Secondary outcomes included the incidence of rate control failure, patient disposition, ED length of stay, hospital length of stay, and in-hospital mortality.

RESULTS: One hundred and twenty-five patients met inclusion criteria, with 57 receiving diltiazem and 68 receiving metoprolol. Overall adverse effects for diltiazem and metoprolol were similar (32% vs. 21%, P = 0.217). However, there was a significantly higher incidence of worsening heart failure symptoms within the diltiazem group (33% vs 15%, P = 0.019). Rate control failure at 60 min did not differ significantly between diltiazem and metoprolol (51% vs 62%, P = 0.277).

CONCLUSIONS: In HFrEF patients with AF, there was no difference in total adverse events in patients treated with IV diltiazem compared to metoprolol. However, the diltiazem group had a higher incidence of worsening CHF symptoms defined as increased oxygen requirement within four hours or initiation of inotropic support within 48 h.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hasbrouck M, Nguyen TT. Acute management of atrial fibrillation in congestive heart failure with reduced ejection fraction in the emergency department. Am J Emerg Med. 2022. PMID: 35623182. doi:10.1016/j.ajem.2022.03.058

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。